老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioVie Inc

6.92
+0.30084.54%
成交量：4.36萬
成交額：29.73萬
市值：1,283.28萬
市盈率：-0.42
高：7.18
開：6.71
低：6.62
收：6.62
資料載入中...
總覽公司新聞公告
2021/01/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/23

重要事件披露

8-K - Current report
2020/09/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/06

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/07/15

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/22

重要事件披露

8-K - Current report
2020/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/11

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/02/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/11/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/11/19

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/11/15

重要事件披露

8-K - Current report
2019/11/07

SEC問詢函

CORRESP [Cover] - Correspondence
2019/11/07

SEC問詢函

CORRESP [Cover] - Correspondence
更多